Trevi Therapeutics, Inc. TRVI Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s accounts payable?
- Trevi Therapeutics, Inc. (TRVI) reported accounts payable of $2.22M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s accounts payable changed year-over-year?
- Trevi Therapeutics, Inc.'s accounts payable increased by 55.9% year-over-year, from $1.42M to $2.22M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s accounts payable has grown at a 14.2% compound annual growth rate (CAGR), from $2.02M to $3.91M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.